Minolast-FXA Tablet SR
Marketer
Leeford Healthcare Ltd
Salt Composition
Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg)
Overview Minolast-FXA Tablet SR
Asthmarelief-FXA SR is a dual-action medication employed in asthma prophylaxis. It alleviates allergic manifestations like nasal discharge, nasal congestion, sneezing, lacrimation, and respiratory congestion. Furthermore, it promotes bronchodilation, easing breathing by relaxing airway muscles. Asthmarelief-FXA SR is administered with or without food, following the physician's prescribed dosage and regimen. Dosage is individualized based on your condition and response. Continue treatment as directed; premature cessation may result in symptom recurrence and exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common adverse effects include nausea, emesis, abdominal pain, diarrhea, dermatitis, pruritus, dyspnea, and cephalalgia. Most are transient and self-limiting. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Disclose any hepatic or renal impairments before commencing treatment to ensure appropriate dosage. Inform your doctor if pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Minolast-FXA Tablet SR
No text provided to rephrase.
Uses of Minolast-FXA Tablet SR
Chronic obstructive pulmonary disease
Major Benefits of Minolast-FXA Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Minolast-FXA Tablet SR whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.
Common Side effects of Minolast-FXA Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Increased white blood cell count
- Increased transaminase level in blood
- Upper respiratory tract infection
- Constipation
- Abdominal discomfort
- Abdominal distension
- Heartburn
- Loss of appetite
- Esophageal bleeding
- Nasal inflammation
How to use Minolast-FXA Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Minolast-FXA Tablet SR whole; avoid chewing, crushing, or breaking it. While you can consume it with or without food, consistent timing is recommended.
How Minolast-FXA Tablet SR works:
Minolast-FXA SR tablets contain a triple-action formula comprising montelukast, fexofenadine, and acebrophylline. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus lessening airway and nasal inflammation and alleviating allergy symptoms. Fexofenadine, an antihistamine, provides relief from allergic manifestations such as nasal discharge, lacrimation, and sneezing. Acebrophylline, a mucolytic agent, facilitates expectoration by reducing mucus viscosity.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Minolast-FXA Tablet SR and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Minolast-FXA Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Minolast-FXA Tablet SR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Minolast-FXA tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Minolast-FXA SR tablets. Dosage modification of Minolast-FXA SR tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Extended-release Minolast-FXA tablets are likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Minolast-FXA Tablet SR :
Should you forget a Minolast-FXA Tablet SR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Minolast-FXA Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |





